Literature DB >> 16982958

Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program.

Jay Onysko1, Colleen Maxwell, Michael Eliasziw, Jenny X Zhang, Helen Johansen, Norm R C Campbell.   

Abstract

This study was conducted to compare the self-reported prevalence and treatment of hypertension in adult Canadians before and subsequent to the implementation of the Canadian Hypertension Education Program in 1999. Data were obtained from 5 cycles of the Canadian Health Surveys between 1994 and 2003 on respondents aged > or = 20 years. Piecewise linear regression was used to calculate the average annual increase in rates, before and after 1999. Between 1994 and 2003, the percentage of adult Canadians aware of being diagnosed with hypertension increased by 51% (from 12.37% to 18.74%; P<0.001), and the percentage prescribed antihypertensive drugs increased by 66% (from 9.57% to 15.86%; P<0.001). After 1999, there was approximately a doubling of the annual rate of increase in the diagnosis of hypertension (from 0.52% of the population per year before 1999 to 1.03% per year after 1999; P<0.001) and the percentage prescribed antihypertensive drugs (from 0.54% of the population per year before 1999 versus 0.98% per year after 1999; P<0.001). The proportion of those aware of the diagnosis of hypertension but not being treated with drugs was reduced by half between 1994 and 2003 (from 31.47% untreated to 15.34% untreated; P<0.001). There was a greater increase in awareness of hypertension and use of antihypertensive drugs among men compared with women after 1999. The large increase in the diagnosis and treatment of hypertension in Canada between 1994 and 2003 is consistent with an overall beneficial effect of the Canadian Hypertension Education Program, including a reduced gender gap in hypertension care.

Entities:  

Mesh:

Year:  2006        PMID: 16982958     DOI: 10.1161/01.HYP.0000242335.32890.c6

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  33 in total

1.  Canadian efforts to prevent and control hypertension.

Authors:  Norman R C Campbell; Guanmin Chen
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

2.  Management of hypertension: Regional variations in a greatly improved landscape.

Authors:  Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2010-10       Impact factor: 5.223

Review 3.  Prevention of heart failure in the elderly: when, where and how to begin?

Authors:  Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

4.  Hypertension management in Canada: good news, but important challenges remain.

Authors:  Sailesh Mohan; Norm R C Campbell
Journal:  CMAJ       Date:  2008-05-20       Impact factor: 8.262

5.  Blood Pressure Control in Canada: Through the Looking-Glass Into a Glass Half Empty?

Authors:  Raj Padwal; Norm R C Campbell
Journal:  Am J Hypertens       Date:  2017-03-01       Impact factor: 2.689

Review 6.  2010 Canadian Hypertension Education Program (CHEP) recommendations: the scientific summary - an update of the 2010 theme and the science behind new CHEP recommendations.

Authors:  Norman R C Campbell; Janusz Kaczorowski; Richard Z Lewanczuk; Ross Feldman; Luc Poirier; Margaret Moy Kwong; Marcel Lebel; Finlay A McAlister; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2010-05       Impact factor: 5.223

7.  Peripheral arterial disease: lack of awareness in Canada.

Authors:  Marge Lovell; Kenneth Harris; Thomas Forbes; Gwen Twillman; Beth Abramson; Michael H Criqui; Paul Schroeder; Emile R Mohler; Alan T Hirsch
Journal:  Can J Cardiol       Date:  2009-01       Impact factor: 5.223

8.  Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors.

Authors:  Douglas S Lee; Maria Chiu; Douglas G Manuel; Karen Tu; Xuesong Wang; Peter C Austin; Michelle Y Mattern; Tezeta F Mitiku; Lawrence W Svenson; Wayne Putnam; William M Flanagan; Jack V Tu
Journal:  CMAJ       Date:  2009-07-20       Impact factor: 8.262

Review 9.  Abdominal obesity: the cholesterol of the 21st century?

Authors:  Jean-Pierre Després; Benoit J Arsenault; Mélanie Côté; Amélie Cartier; Isabelle Lemieux
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

10.  Laboratory testing in newly treated elderly hypertensive patients without co-morbidities: a population-based cohort study.

Authors:  Finlay Aleck McAlister; Karen Tu; Sumit R Majumdar; Rajdeep Padwal; Zhongliang Chen; Norman R C Campbell
Journal:  Open Med       Date:  2007-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.